← Back to Search

Treatment for Frontotemporal Dementia

N/A
Waitlist Available
Led By Howie Rosen, MD
Research Sponsored by The Bluefield Project to Cure Frontotemporal Dementia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 36 months
Awards & highlights

Summary

This is a biomarker study designed to collect and analyze blood specimens from individuals carrying known familial frontotemporal lobar degeneration (f-FTLD) mutations compared to a control group of individuals without known f-FTLD mutations. The NSP is an ancillary study to the ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration" (ALLFTD) study, NCT04363684. More information can be found at https://www.allftd.org/.

Eligible Conditions
  • Frontotemporal Dementia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~36 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 36 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Neurofilament Light Chain Levels
Secondary outcome measures
Intersubject variability of plasma NfL measurements
Logistics measure
Other outcome measures
Clinical and MRI correlates
Other biomarker evaluation

Find a Location

Who is running the clinical trial?

The Bluefield Project to Cure Frontotemporal DementiaLead Sponsor
2 Previous Clinical Trials
1,497 Total Patients Enrolled
1 Trials studying Frontotemporal Dementia
1,489 Patients Enrolled for Frontotemporal Dementia
Mayo ClinicOTHER
3,298 Previous Clinical Trials
3,958,110 Total Patients Enrolled
12 Trials studying Frontotemporal Dementia
11,915 Patients Enrolled for Frontotemporal Dementia
University of California, San FranciscoOTHER
2,551 Previous Clinical Trials
15,257,551 Total Patients Enrolled
15 Trials studying Frontotemporal Dementia
7,881 Patients Enrolled for Frontotemporal Dementia
~118 spots leftby Dec 2026